Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.20 per share for the quarter.
Guardian Pharmacy Services Stock Performance
Guardian Pharmacy Services stock opened at $19.58 on Monday. The firm has a fifty day simple moving average of $21.09. Guardian Pharmacy Services has a 1-year low of $14.16 and a 1-year high of $25.74.
Analyst Ratings Changes
Separately, Truist Financial lifted their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, November 15th.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- Short Selling – The Pros and Cons
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Consumer Discretionary Stocks Explained
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- The 3 Best Retail Stocks to Shop for in August
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
